The global COPD and asthma devices market size reached US$ 43.4 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 60.4 Billion by 2028, exhibiting a CAGR of 5.66% during 2022-2028.
Chronic obstructive pulmonary disease (COPD) is an inflammatory disease that leads to obstructed airflow from the lungs. Its early symptoms include shortness of breath, wheezing, chest tightness, chronic cough with or without mucus, frequent cold, and throat soreness. On the other hand, asthma, also known as bronchial asthma, is a respiratory disorder that affects the airways in the lungs. Its symptoms are shortness of breath, chest tightness, trouble sleeping, and coughing or wheezing attacks. These respiratory diseases are treated using various devices that help deliver inhaled medication. COPD and asthma devices, also known as pulmonary drug delivery devices, are used as permanent treatment or rescue therapy for respiratory diseases. As a result, they are gaining immense traction across the globe.
Drug Powdered Inhalers (DPIs)
Metered Dose Inhalers (MDIs)
Soft Mist Inhalers
Nebulizers
Compressor Nebulizers
Ultrasonic Nebulizers
Mesh Nebulizers
Online Pharmacies
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
What has been the impact of COVID-19 on the global COPD and asthma devices market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the indication?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global COPD and asthma devices market and who are the key players?
What is the degree of competition in the industry?
Chronic obstructive pulmonary disease (COPD) is an inflammatory disease that leads to obstructed airflow from the lungs. Its early symptoms include shortness of breath, wheezing, chest tightness, chronic cough with or without mucus, frequent cold, and throat soreness. On the other hand, asthma, also known as bronchial asthma, is a respiratory disorder that affects the airways in the lungs. Its symptoms are shortness of breath, chest tightness, trouble sleeping, and coughing or wheezing attacks. These respiratory diseases are treated using various devices that help deliver inhaled medication. COPD and asthma devices, also known as pulmonary drug delivery devices, are used as permanent treatment or rescue therapy for respiratory diseases. As a result, they are gaining immense traction across the globe.
COPD and Asthma Devices Market Trends:
The growing global geriatric population, which is highly susceptible to chronic respiratory disorders, represents one of the key factors positively influencing the market. In addition, rising occurrences of respiratory diseases caused due to the rising smoking of cigarettes are increasing the sales of COPD and asthma devices. Apart from this, the increasing expenditure on healthcare and continuous automation in the healthcare industry are contributing to the market growth. The widespread adoption of advanced medical solutions is offering lucrative growth opportunities to manufacturers across the globe. At present, healthcare practitioners and pulmonary diseases specialists are preferring a combination of a drug and a device on account of their fast and effective outcome. Furthermore, the expansion of chemical industries is resulting in the rising environmental pollution level and breathing problems, which, in turn, is driving the market. Additionally, the introduction of portable drug delivery devices is propelling the market growth.Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global COPD and asthma devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, indication and distribution channel.Breakup by Product:
- Inhalers
Drug Powdered Inhalers (DPIs)
Metered Dose Inhalers (MDIs)
Soft Mist Inhalers
Nebulizers
Compressor Nebulizers
Ultrasonic Nebulizers
Mesh Nebulizers
Breakup by Indication:
- Asthma
Breakup by Distribution Channel:
- Retail Pharmacies
Online Pharmacies
Breakup by Region:
- North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Adherium Limited, Aristopharma Ltd., AstraZeneca PLC, Baxter International Inc., Boehringer Ingelheim International GmbH, Cohero Health Inc., Koninklijke Philips N.V., Omron Corporation, Pari Respiratory Equipment Inc., Recipharm AB and Verona Pharma plc.Key Questions Answered in This Report:
How has the global COPD and asthma devices market performed so far and how will it perform in the coming years?What has been the impact of COVID-19 on the global COPD and asthma devices market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the indication?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global COPD and asthma devices market and who are the key players?
What is the degree of competition in the industry?
Table of Contents
1 Preface2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global COPD and Asthma Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Inhalers
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Drug Powdered Inhalers (DPIs)
6.1.2.2 Metered Dose Inhalers (MDIs)
6.1.2.3 Soft Mist Inhalers
6.1.3 Market Forecast
6.2 Nebulizers
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Compressor Nebulizers
6.2.2.2 Ultrasonic Nebulizers
6.2.2.3 Mesh Nebulizers
6.2.3 Market Forecast
7 Market Breakup by Indication
7.1 Asthma
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 COPD
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Retail Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hospitals
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacies
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Adherium Limited
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Aristopharma Ltd.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 AstraZeneca PLC
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Baxter International Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Boehringer Ingelheim International GmbH
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Cohero Health Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Koninklijke Philips N.V.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Omron Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Pari Respiratory Equipment Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Recipharm AB
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Verona Pharma plc
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
List of Figures
Figure 1: Global: COPD and Asthma Devices Market: Major Drivers and Challenges
Figure 2: Global: COPD and Asthma Devices Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: COPD and Asthma Devices Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: COPD and Asthma Devices Market: Breakup by Product (in %), 2022
Figure 5: Global: COPD and Asthma Devices Market: Breakup by Indication (in %), 2022
Figure 6: Global: COPD and Asthma Devices Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: COPD and Asthma Devices Market: Breakup by Region (in %), 2022
Figure 8: Global: COPD and Asthma Devices (Inhalers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: COPD and Asthma Devices (Inhalers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: COPD and Asthma Devices (Nebulizers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: COPD and Asthma Devices (Nebulizers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: COPD and Asthma Devices (Asthma) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: COPD and Asthma Devices (Asthma) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: COPD and Asthma Devices (COPD) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: COPD and Asthma Devices (COPD) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: COPD and Asthma Devices (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: COPD and Asthma Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: COPD and Asthma Devices (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: COPD and Asthma Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: COPD and Asthma Devices (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: COPD and Asthma Devices (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: North America: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: North America: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: United States: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: United States: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Canada: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Canada: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Asia-Pacific: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Asia-Pacific: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: China: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: China: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Japan: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Japan: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: India: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: India: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: South Korea: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: South Korea: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Australia: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Australia: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Indonesia: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Indonesia: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Others: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Europe: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Europe: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Germany: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Germany: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: France: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: France: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: United Kingdom: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: United Kingdom: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Italy: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Italy: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Spain: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Spain: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Russia: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Russia: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Others: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Latin America: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Latin America: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Brazil: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Brazil: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Mexico: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Mexico: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Others: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Middle East and Africa: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Middle East and Africa: COPD and Asthma Devices Market: Breakup by Country (in %), 2022
Figure 70: Middle East and Africa: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Global: COPD and Asthma Devices Industry: SWOT Analysis
Figure 72: Global: COPD and Asthma Devices Industry: Value Chain Analysis
Figure 73: Global: COPD and Asthma Devices Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: COPD and Asthma Devices Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: COPD and Asthma Devices Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: COPD and Asthma Devices Market Forecast: Breakup by Indication (in Million US$), 2023-2028
Table 4: Global: COPD and Asthma Devices Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 5: Global: COPD and Asthma Devices Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: COPD and Asthma Devices Market: Competitive Structure
Table 7: Global: COPD and Asthma Devices Market: Key Players
Companies Mentioned
- Adherium Limited
- Aristopharma Ltd.
- AstraZeneca PLC
- Baxter International Inc.
- Boehringer Ingelheim International GmbH
- Cohero Health Inc.
- Koninklijke Philips N.V.
- Omron Corporation
- Pari Respiratory Equipment Inc.
- Recipharm AB
- Verona Pharma plc.
Methodology
LOADING...
